Dear Editor, Microbiome affects many aspects of human health and disease and elicits a wide range of host responses including remarkable epigenetic changes such as DNA methylation, histone modification and non-coding RNA expression. 1 A still poorly explored area of microbiome-host interaction is the response of host RNA modification. N 6 -methyladenosine (m 6 A) is the most abundant mRNA modification in mammalian cells, occurring at~3 modified adenosine residues per transcript. The m 6 A mapping and biology have been extensively studied recently. 2 At the physiological level, m 6 A affects embryonic development, circadian clock, immunoresponse, and others. At the cellular and molecular level, m 6 A affects all key aspects of mRNA processing, translation and decay. Importantly, m 6 A is a predominant, transcriptome-wide mark that is responsive to environmental changes; this dynamic m 6 A pattern is maintained by the writer enzyme complex containing the METTL3 and METTL14 proteins, and two eraser enzymes of FTO and ALKBH5. 3, 4 We investigated the host response marked by m 6 A in the transcriptome to the presence of microbiome in mice (Fig. 1a) . We employed one group of germ-free (GF) mice to identify the host response to the absence, and the other group of specific pathogen-free (SPF) mice to identify the host response to the presence of microbiome. We validated the absence of gut microbiota in our GF mice by PCR of the representative 16S genes (Supplementary information, Fig. S1a ). 16S rRNA gene amplicon sequencing of the SPF mice showed that all three mice in this group had similar bacterial compositions at the genus level, which were mainly blautia and roseburia (Supplementary information, Fig. S1b ).
We harvested three tissues of GF and SPF mice of the same genetic background at 4 weeks of age, brain, intestine, and liver, and performed m 6 A analysis in polyA-selected RNA by liquid chromatography/mass spectrometry (LC/MS) to determine the total m 6 A/A ratios and by the m A-MeRIP sequencing to determine the transcriptomic m 6 A pattern and distribution. These three tissues were selected based on their pervasive studies in the literature on the GF and SPF mouse physiology. The m 6 A/A ratios of the polyA-selected RNA are in the expected range of 0.2%-0.6%; brain showed the highest m 6 A content for both GF and SPF mice, and brain and intestine showed higher m 6 A content in the GF mice (Fig. 1b) . The polyA-selected RNA in kidney also showed higher m Table S1 ) showed the well-known m 6 A pattern across the mRNA transcripts such as the strong enrichment of m 6 A peaks at the junction of coding region (CDS) and 3′ UTR (Fig. 1c) . We identified the m 6 Acontaining transcripts that were present in all three GF or SPF mouse groups as "high confidence" data and used only these for further analysis ( A-MeRIP data. We identified several differences in m 6 A patterns between the GF and SPF tissues. First, the m 6 A peak distributions had distinct shapes among these tissues (Fig. 1c) . When benchmarked against the m 6 A cluster near the stop codon, the GF brain m 6 A occurrence was higher in the CDS region compared to the SPF brain. Second, the m 6 A installation consensus sequences in GF and SPF tissues were deviated in brain, but identical in intestine and liver (Fig. 1d) . Third, only 25% of the m 6 A peaks in the GF brain overlapped with those in SPF brain, whereas > 59% of the m 6 A peaks overlapped in GF and SPF intestine and liver (Fig. 1e) . The large brain m 6 A peak differences was also shown by principal component analysis and their statistical significance in gene ontology analysis across all tissues ( Fig. 1f and Supplementary information, Fig. S5 ), and was not derived from global transcript expression differences (Supplementary information, Fig. S6 ). On the other hand, SPF brain may have higher m 6 A modification fraction for some common m 6 A peaks (Supplementary information, Fig. S7 ). All together, these results indicate that the presence of microbiome has a profound influence on the cellular mRNA m 6 A patterns in a tissuedependent manner. Alteration of the m 6 A pattern is most pronounced in the brain, where the m 6 A methylome is substantially reduced in the presence of microbiome.
We performed in-depth analysis for the GF and SPF brain tissues to further elucidate the m 6 A alteration in the mRNA (a representative read coverage plot shown in Fig. 1g ). Among the 8643 and 2750 m 6 A-containing transcripts, 67 and 80% had only one m 6 A peak in the GF and SPF brains, respectively, and the GF/ SPF transcript ratio was 2.6 ( Fig. 1h) . However, this GF/SPF ratio for the transcripts containing two or more m 6 A peaks steadily increased to 4.4 for two, 6.7 for three, and 9.2 for more than three m 6 A peaks. GF brain transcripts also had a broader distribution of m 6 A peak/exon ratios (Fig. 1i) . These results indicate that more m 6 A clusters are present in individual GF than SPF brain transcripts. The abundance of the m 6 A-containing transcripts was lower in GF than SPF brain (Fig. 1j) , which might be associated with a major known role of m 6 A in accelerating mRNA decay. 7 More m 6 A peaks were present in all three mRNA regions in GF than SPF brain (Fig. 1k) . The m 6 A location in different mRNA regions has been associated with different functions. For example, m 6 A in the 5′ UTR enhances translation through eIF3-dependent recruitment of the ribosome; 8 m 6 A in the 3′ UTR regulates mRNA stability and translation efficiency that depend on the m 6 A reader proteins YTHDF1, YTHDF2 and YTHDF3; m 6 A in the CDS regulates splicing that involves the m 6 A reader proteins YTHDC1, hnRNPC and hnRNPG, 9,10 and codon-dependent translational efficiency.
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The large increase of the m 6 A peaks in the GF brain therefore could affect the m 6 A-dependent mRNA function in several different ways. This multifaceted m 6 A effects in the brain were consistent with the reactome analysis of biological pathways that showed the top enriched categories for m 6 A-containing transcripts, including mRNA splicing, cell cycle and signaling (Fig. 1l) .
The GF brain may represent an under-developed state due to the lack of its microbiome exposure. [12] [13] [14] To obtain insight into whether this idea applies to m 6 A in the transcriptome, we compared our results with the published m 6 A patterns from the mouse embryonic brain 15 using only the high-confidence m 6 Acontaining transcripts from both studies (Fig. 1m) . The E13.5 embryonic brain (7701) had a comparable amount of m 6 Acontaining transcripts to the 4-week-old GF brain (8, 643) ; the overlap between them was 60% for embryonic brain and 54% for GF brain. The embryonic brain (7701) had a much higher amount of m 6 A-containing transcripts than the 4-week-old SPF brain (2750); the overlap between them was 20% for embryonic brain and 57% for SPF brain. Ninety-seven percent of all GF and SPF brain m 6 A-containing transcripts overlapped, which explained the similar overlapping percentage of GF and SPF with the embryonic transcripts. These results suggest that in regards to m 6 A modification, the GF brain more closely resembles the embryonic brain than the SPF brain of the same age.
To obtain mechanistic understanding of m 6 A changes in GF and SPF tissues, we measured the levels of the mRNA m 6 A writer proteins METTL3 and METTL14, and the m 6 A eraser proteins FTO and ALKBH5 by western blot. We found that both m 6 A writer proteins and both m 6 A eraser proteins were highly overexpressed in the GF brain compared to the SPF brain (Figs. 1n, o, and  Supplementary information, Fig. S8 ). In contrast to brain, the differential expression of these proteins in the intestine and liver was much less noticeable without a uniform trend (Fig. 1p) . These results correlate well with the finding that the brain has the largest difference in the m 6 A pattern among the three tissues examined here. Furthermore, the simultaneous overexpression of the m 6 A writer complex and the erasers in the same tissue should increase the ability to rapidly tune the m 6 A pattern upon environmental changes.
In summary, here we show that the microbiome has a strong effect on host m 6 A mRNA modification. Among the brain, intestine and liver tissues, the largest effect is present in the brain, which is associated with overexpression of both m 6 A writer and eraser proteins; this result suggests that the brain tissue may be more sensitive to adjust the m 6 A methylome in response to the microbiome than other tissues. Future studies will reveal the specific microbial species and the molecular mechanisms that regulate the host m 6 A methylome. A writer and eraser protein levels in the brain. Values are the means ± SD, n = 3, *P < 0.05, **P < 0.01, ***P < 0.001, Student's t-test. p Quantitation of m 6 A writer and eraser protein levels in the intestine and liver. Values are the means ± SD, n = 3, *P < 0.05, Student's t-test
